These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2785642)

  • 1. Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected].
    Chatenoud L; Ferran C; Reuter A; Legendre C; Gevaert Y; Kreis H; Franchimont P; Bach JF
    N Engl J Med; 1989 May; 320(21):1420-1. PubMed ID: 2785642
    [No Abstract]   [Full Text] [Related]  

  • 2. [T lymphocyte activation induced in vivo by the first injection of OKT3 monoclonal antibodies].
    Chatenoud L; Ferran C; Reuter A; Legendre C; Gevaert Y; Kreis H; Franchimont P; Bach JF
    C R Acad Sci III; 1988; 307(19):833-6. PubMed ID: 3146414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cascade modulation by anti-tumor necrosis factor monoclonal antibody of interferon-gamma, interleukin 3 and interleukin 6 release after triggering of the CD3/T cell receptor activation pathway.
    Ferran C; Dy M; Sheehan K; Schreiber R; Grau G; Bluestone J; Bach JF; Chatenoud L
    Eur J Immunol; 1991 Oct; 21(10):2349-53. PubMed ID: 1833202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human gamma interferon production by leukocytes induced with monoclonal antibodies recognizing T cells.
    von Wussow P; Platsoucas CD; Wiranowska-Stewart M; Stewart WE
    J Immunol; 1981 Sep; 127(3):1197-200. PubMed ID: 6167620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute toxicity of anti-CD3 monoclonal antibody in mice: a model for OKT3 first dose reactions.
    Alegre M; Depierreux M; Florquin S; Najdovski T; Vandenabeele P; Abramowicz D; Leo O; Deschodt-Lanckman M; Goldman M
    Transplant Proc; 1990 Aug; 22(4):1920-1. PubMed ID: 2143864
    [No Abstract]   [Full Text] [Related]  

  • 6. OKT3 monoclonal antibody induces production of colony-stimulating factor(s) for granulocytes and macrophages in cultures of human T lymphocytes and adherent cells.
    Platzer E; Rubin BY; Lu L; Welte K; Broxmeyer HE; Moore MA
    J Immunol; 1985 Jan; 134(1):265-71. PubMed ID: 3917276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular origin and interactions involved in gamma-interferon production induced by OKt3 monoclonal antibody.
    Chang TW; Testa D; Kung PC; Perry L; Dreskin HJ; Goldstein G
    J Immunol; 1982 Feb; 128(2):585-9. PubMed ID: 6172498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies.
    Bemelmans MH; Abramowicz D; Gouma DJ; Goldman M; Buurman WA
    J Immunol; 1994 Jul; 153(2):499-506. PubMed ID: 8021491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura.
    Girardin E; Grau GE; Dayer JM; Roux-Lombard P; Lambert PH
    N Engl J Med; 1988 Aug; 319(7):397-400. PubMed ID: 3135497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia.
    Dubey S; Shukla P; Nityanand S
    Ann Hematol; 2005 Sep; 84(9):572-7. PubMed ID: 15815907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody directed against the human intercellular adhesion molecule (ICAM-1) modulates the release of tumor necrosis factor-alpha, interferon-gamma and interleukin 1.
    Geissler D; Gaggl S; Möst J; Greil R; Herold M; Dietrich M
    Eur J Immunol; 1990 Dec; 20(12):2591-6. PubMed ID: 1980110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation.
    Ferran C; Sheehan K; Dy M; Schreiber R; Merite S; Landais P; Noel LH; Grau G; Bluestone J; Bach JF
    Eur J Immunol; 1990 Mar; 20(3):509-15. PubMed ID: 2138557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo T lymphocyte activation induced in mice following the injection of anti-CD3 monoclonal antibody.
    Ferran C; Bluestone J; Bach JF; Chatenoud L
    Transplant Proc; 1990 Aug; 22(4):1922-3. PubMed ID: 2143865
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of T10Bg.1A-31 and OKT3 in treating acute renal allograft rejection.
    Lucas BA; Waid TH; Thompson JS; Brown SA; Munch LC; McKeown JW; Kryscio RJ; Prebeck RJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):543-5. PubMed ID: 8438406
    [No Abstract]   [Full Text] [Related]  

  • 15. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis.
    Mizuhara H; Uno M; Seki N; Yamashita M; Yamaoka M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
    Hepatology; 1996 Jun; 23(6):1608-15. PubMed ID: 8675184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
    Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL
    Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-independent protective effect of recombinant IFN-gamma against acute toxoplasmosis in T cell-deficient mice.
    Suzuki Y; Joh K; Kobayashi A
    J Immunol; 1991 Oct; 147(8):2728-33. PubMed ID: 1918987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell unresponsiveness to the mitogenic activity of OKT3 antibody results from a deficiency of monocyte Fc gamma receptors for murine IgG2a and inability to cross-link the T3-Ti complex.
    Ceuppens JL; Bloemmen FJ; Van Wauwe JP
    J Immunol; 1985 Dec; 135(6):3882-6. PubMed ID: 2933454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vivo use of OKT3 monoclonal antibodies in recipients of renal allografts].
    Chatenoud L; Bach JF
    Nephrologie; 1987; 8(3):95-8. PubMed ID: 3309702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [T lymphocyte activation induced in vivo in different strains of mice after injection of anti-CD3 antibodies: prevention by an anti- TNF antibody].
    Ferran C
    Nephrologie; 1993; 14(1):23-4. PubMed ID: 8502345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.